Community-Acquired Skin Infections in the Age of Methicillin-Resistant Organisms Table 12. Skin infection type, treatment characteristics, and whether MRSA cultured for prospective patientsClinicNo. Useable Skin and Soft Tissue Infection Prospective Forms n (%)Abscess Only n (%)Cellulitis Only n (%)Both Abscess & Cellulitis n (%)Incision and Drainage Done n (%)Culture Sent n (%)Antibiotic Prescribed at Initial Visit n (%)MRSA Positive n (%)181 (14)4 (57)2 (29)2 (25)2 (25%)8 (100)02000000003232 (9)20 (87)1 (4)3 (13)12 (52)21 (91)4 (33)492 (22)4 (44)3 (33)5 (56)6 (67)9 (100)4 (67)5113 (30)3 (30)4 (40)5 (46)7 (64)11 (100)3 (43)600000000751 (25)3 (75)01 (20)2 (40)5 (100)1 (50)8101 (10)6 (60)02 (20)5 (50)9 (90)09305 (17)17 (57)8 (27)5 (17)6 (20)30 (100)1 (17)10183 (17)9 (50)6 (33)9 (50)10 (56)18 (100)2 (20)Total11418 (17)66 (61)24 (22)32 (28)49 (43)111 (97)15Return to Contents Table 13. Comparison of retrospective and prospective data, all cases Retrospective N = 263 N (%)Prospective N = 114 N (%)P-ValueDemographicsGender Female Male 131 (50) 132 (50) 66 (58) 48 (42)0.149Age groups < 20 20 to < 40 40 to < 65 65 to 96 27 (24) 34 (30) 38 (34) 14 (12) 60 (23) 66 (25) 88 (34) 48 (18)0.489Age group (years) < 40 ≥ 40 126 (48) 136 (52) 61 (54) 52 (46)0.295Rurality Non-rural Rural 183 (70) 80 (30) 82 (73) 31 (27)0.561Insurance Private Medicaid Medicare Uninsured 152 (59) 44 (17) 44 (17) 18 (7) 76 (70) 20 (19) 10 (9) 2 (2)0.037Race Caucasian Non-Caucasian 191 (96) 8 (4) 107 (94) 7 (6)0.398Ethnicity Hispanic Non-Hispanic 10 (5) 178 (95) 2 (2) 112 (98)0.124Patient Presenting CharacteristicsSite of Infection Face/neck Groin/pubic/lower extremities Thorax/upper extremities 34 (13) 122 (47) 104 (40) 15 (14) 47 (44) 45 (42)0.871Initial temperature (°F) < 99° ≥ 99° 206 (90) 24 (10) 101 (91) 10 (9) 0.681Duration of infection prior to being seen < 5 days ≥ 5 days 132 (60) 89 (40) 65 (61) 41 (39)0.783Patient hospitalized with infection Yes No 11 (4) 252 (96) 3 (3) 109 (97)0.482Patient had at least 1 risk factor for MRSA Yes No 69 (26) 194 (74) 39 (34) 75 (66)0.116Patient had diabetes Yes No 35 (13) 228 (87) 19 (17) 95 (83)0.393Wound Type Abscess only Cellulitis only Abscess and cellulitis 93 (36) 143 (54) 27 (10) 18 (17) 66 (61) 24 (22) < 0.001TreatmentIncision and drainage done Yes No 85 (32) 178 (67) 32 (28) 82 (72)0.413Culture done Yes No 92 (44) 171(65) 50 (35) 64 (56)0.102Wound packed Wound packed Wound not packed Incision and drainage not done 30 (11) 55 (21) 178 (68) 8 (7) 22 (20) 82 (73)0.403Only for those ( n = 115) who had an incision and drainage done Wound packed Wound not packed 30 (35) 55 (65) 8 (27) 22 (73)0.388MRSA cultured Yes No 45 (49) 47 (51) 15 (30) 35 (70)0.029Antibiotics PrescribedAntibiotic prescribed at initial visit Yes No 246 (93) 17 (7) 111 (97) 3 (3)0.127Antibiotic(s) at initial visit covered MRSA Yes No 70 (29) 176 (71) 58 (51) 56 (49)< 0.001Antibiotics were prescribed that covered MRSA at some time during infection Yes No 91 (37) 157 (63) 68 (60) 46 (40)< 0.001Total number of antibiotics used over the course of the infection ≤ 2 > 2 241 (92) 22 (8) 103 (90) 11 (10)0.685Total number of antibiotics used over course of infection 0 1 2 3 4 5 6 15 (6) 176 (67) 50 (19) 16 (6) 3 (1) 3 (1) 0 1 (1) 77 (67) 25 (22) 8 (7) 2 (2) 0 1 (1)0.194Return to Contents Table 14. Comparison of retrospective and prospective treatments for any infection that had an abscess N=162 Retrospective Abscess Only and Abscess & Cellulitis N = 120Prospective Abscess Only and Abscess and Cellulitis N = 42P-ValueIncision and drainage done Yes No 83 (69) 37 (31) 24 (57) 18 (43)0.157Culture done Yes No 58 (48) 62 (52) 26 (62) 16 (38)0.130Antibiotic prescribed at first visit Yes No 108 (90) 12 (10) 41 (98) 1 (2)0.118Initial antibiotics covered MRSA Yes No 46 (43) 62 (57) 28 (67) 14 (33)0.008Antibiotics covered MRSA at some time during infection Yes No 56 (51) 53 (49) 28 (67) 14 (33)0.090Return to Contents Proceed to Next Section Current as of March 2011 Internet Citation: Community-Acquired Skin Infections in the Age of Methicillin-Resistant Organisms. March 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/final-reports/mrsa/iowa_mrsatabs12-14.html